Distinct patterns of urokinase receptor (uPAR) expression by leukemic cells and peripheral blood cells

Thrombosis and Haemostasis

Volumn 76, Issue 6, 1996, Pages 1009-1019

  Jardí, Mercè ^a   Inglés Esteve, Julia ^a   Burgal, Maria ^b   Azqueta, Carmen ^a   Velasco, Francisco ^c   López Pedrera, Chary ^c   Miles, Lindsey A ^d   Félez, Jordi ^a  

^a HOSPITAL DURAN I REYNALS   (Spain)

^b CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; PLASMIN; PLASMINOGEN ACTIVATOR; RECEPTOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; UROKINASE RECEPTOR;

ARTICLE; B LYMPHOCYTE; BLOOD CELL; BONE MARROW CELL; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL; LYMPHOID CELL LINE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; T LYMPHOCYTE; TISSUE DISTRIBUTION;

EID: 0030456959     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650701     Document Type: Article

References (67)

1. Nielsen LS, Kellerman GM, Behrendt N, Picone R, Danø K, Blasi F. A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. J Biol Chem 1988; 263: 2358-63.
2. 2-terminal amino acid sequence and glycosylation variants. J Biol Chem 1990; 265: 6453-60.
3. Ploug M, Ronne E, Behrendt N, Jensen AL, Blasi F, Danø K. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J Biol Chem 1991; 266: 1926-33.
4. Blasi F. Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Bio Essays 1993; 15: 105-11.
5. Pollanen J. The N-Terminal domain of human urokinase receptor contains two distinct regions critical for ligand recognition. Blood 1993; 82: 2719.
6. Estreicher A, Wohlwend A, Belin D, Scleuning W, Vassalli JD. Characterization of the cellular binding site for the urokinase-type plasminogen activator. J Biol Chem 1989; 264: 1180-9.
7. Plow EF, Felez J, Miles LA. Cellular Regulation of Fibrinolysis. Thromb Haemost 1991; 66: 32-6.
8. Vassalli J. The urokinase receptor. Fibrinolysis 1994; 8: 172-81.
9. Blasi F, Conese M, Moller LB, Pedersen N, Cavallaro U, Cubellis MV, Fazioli F, Hernandez-Marrero L, Limongi P, Munoz-Canoves P, Resnati M, Riitinen L, Sidenius N, Soravia E, Soria MR, Stoppelli MP, Talarico D, Teesalu T, Valcamonica S. The Urokinase Receptor: Structure, Regulation and Inhibitor-mediated Internalization. Fibrinolysis 1994; 8: 182-8.
10. Danø K, Behrendt N, Brunner N, Ellis V, Ploug M, Pyke C. The urokinase receptor: Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 1994; 8: 189-203.
11. Pedersen H, Brünner N, Francis D, Osterlind K, Ronne E, Hansen HH, Danø K, Grondahl-Hansen J. Prognostic impact of urokinase, urokinase receptor, and type I plasminogen activator inhibitor in squamous and large cell lung cancer tissue. Cancer Res 1994; 54: 4671-75.
12. Carriero MV, Franco P, Del Vecchio S, Massa O, Botti G, D'Aiuto G, Stoppelli MP, Salvatore M. Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies. Cancer Res 1994; 54: 5445-54.
13. Mazzieri R, Hoyer-Hansen G, Ronne E, Lober D, Vagnarelli P, Raimondi E, De Carli L, Danø K, Mignatti P. Urokinase and urokinase receptor expression in somatic cell hybrids. Fibrinolysis 1994; 8: 344-52.
14. Mohanam S, Sawaya RE, Yamamoto M, Bruner JM, Nicholson GL, Rao JS. Proteolysis and invasiveness of brain tumors: Role of urokinasetype plasminogen activator receptor. J Neurooncol 1994; 22: 153-60.
15. Semi U, Fibbi G, Anichini E, Zamperini A, Pucci M, Mannoni A, Matucci A, Benucci M, Del Rosso A, Del Rosso M. Plasminogen activator and receptor in osteoarthritis. J Rheumatol 1995; 22 Suppl. 43: 120-2.
16. Pyke C, Ralfkiær E, Ronne E, Hoyer-Hansen G, Kirkeby L, Dano K. Immunohistochemical detection of the receptor for urokinase plasminogen activator in human colon cancer. Histopathology 1994; 24: 131-8.
17. Bianchi E, Cohen RL, Thor AT,Todd RF, III, Mizukami IF, Lawrence DA, Ljung BM, Shuman MA, Smith HS. The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res 1994; 54: 861-6.
18. Ronne E, Hoyer-Hansen G, Brünner N, Pedersen H, Rank F, Osborne CK, Clark GM, Danø K, Grondahl-Hansen J. Urokinase receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies. Breast Cancer Res Treat 1995; 33: 199-207.
19. Nykjær A, Moller B, Todd RF, III, Christensen T, Andreasen PA, Gliemann J, Petersen CM. Urokinase receptor: An activation antigen in human T lymphocytes. J Immunol 1994; 152: 505-16.
20. Plesner T, Ralfkiær E, Wittrup M, Johnsen H, Pyke C, Pedersen TL, Hansen NE, Danø K. Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue. Am J Clin Pathol 1994; 102: 835-41.
21. Nykjær A, Petersen CM, Moller B, Andreasen PA, Gliemann J. Identification and characterization of urokinase receptors in natural killer cells and T-cell-derived lymphokine activated killer cells. FEBS Lett 1992; 300: 13-7.
22. Nykjaer A, Petersen CM, Christensen EI, Davidsen O, Gliemann J. Urokinase receptors in human monocytes. Biochim Biophys Acta 1990; 1052: 399-407.
23. Miles LA, Plow EF. Receptor mediated binding of the fibrinolytic components, plasminogen and urokinase, to peripheral blood cells. Thromb Haemost 1987; 58: 936-42.
24. Todd RF, III., Bamathan ES, Bohuslav J, Chapman HA, Cohen RL, Félez J, Howell A, Johnson JG, Knapp W, Kramer M, Miles LA, Nykjaer A, Ralfkiaer E, Shuren E. M15 Cluster Report: CD87. In: Leucocyte Typing V: White Cell Differentiation Antigens. Schloosman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein RL, Springer TA, Tedder TF, Todd RF, III, eds. Oxford: Oxford University Press, 1995: 932-9.
25. Jardi M, Ingles-Esteve J, Fabregas P, Felez J. Different expression of urokinase receptors (uPAR) among leukemic cells. Thromb Haemost 1993; 69: 608-A:231. Abstract.
26. Plesner T, Ploug M, Ellis V, Ronne E, Hoyer-Hansen G, Wittrup M, Lindhardt Pedersen T, Tscherning T, Danø K, Hansen NE.The receptor for urokinase-type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils. Blood 1994; 83: 808-15.
27. Deutsch DG, Mertz ET. Plasminogen: Purification from human plasma by affinity chromatography. Science 1970; 170: 1995-6.
28. Miles LA, Plow EF. Topography of the high-affinity lysine binding site of plasminogen as defined with a specific antibody probe. Biochemistry 1986; 25: 6926-33.
29. Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein RL, Springer TA, Tedder TF, Todd RF. CD antigens 1993. J Immunol 1994; 152: 1.
30. Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein RL, Springer TA, Tedder TF, Todd RF. CD antigens 1993. Blood 1994; 83: 879-80.
31. Plow EF, Freaney DE, Plescia J, Miles LA. The plasminogen system and cell surfaces: Evidence for plasminogen and urokinase receptors on the same cell type. J Cell Biol 1986; 103: 2411-20.
32. Phillips DR, Morrison M. Exposed protein on the intact human erythrocyte. Biochemistry 1971; 10: 1766-71.
33. Félez J, Chanquia CJ, Fabregas P, Plow EF, Miles LA. Competition between Plasminogen and t-PA for Cellular Binding Sites. Blood 1993; 82: 2433-41.
34. Félez J, Chanquia CJ, Levin EG, Miles LA, Plow EF. Binding of tissue plasminogen activator to human monocytes and monocytoid cells. Blood 1991; 78: 2318-27.
35. Félez J, Miles LA, Plescia J, Plow EF. Regulation of Plasminogen Receptor Expression on Human Monocytes and Monocytoid Cell Lines. J Cell Biol 1990; 111: 1673-83.
36. Miles LA, Plow EF. Binding and activation of plasminogen on the platelet surface. J Biol Chem 1985; 260: 4303-11.
37. Miles LA, Ginsberg MH, White JG, Plow EF. Plasminogen interacts with human platelets through two distinct mechanisms. J Clin Invest 1986; 77: 2001-9.
38. Bennett JM, Catovsky D, Daniel MT. Proposed revised criteria for the classification of acute myeloid leukemia: A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 626-9.
39. Roldan AL, Cubellis MV, Masucci MT, Behrendt N, Lund LR, Danø K, Appella E, Blasi F. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J 1990; 9: 467-74.
40. Lund LR, Ronne E, Roldan AL, Behrendt N, Romer J, Blasi F, Danø K. Urokinase receptor mRNA level and gene transcription are strongly and rapidly increased by phorbol myristate acetate in human monocyle-like U937 cells. J Biol Chem 1991; 266: 5177-81.
41. McCrae KR, Zini JM, Mazar A, Henkin J, Graham C, Lala PK. Human placental trophoblasts express receptors for single chain urokinase-type plasminogen activator. Third Inter.Workshop Molec & Cellul Biol of Plasminogen Activation 1991; 1: 9 Abstract.
42. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
43. Hoyer-Hansen G, Ronne E, Solberg H, Behrendt N, Ploug M, Lund LR, Ellis V, Danø K. Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain. J Biol Chem 1992; 267: 18224-9.
44. Herz J, Clouthier DE, Hammer RE. LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation. Cell 1992; 71: 411-21.
45. Strickland DK, Kounnas MZ, Williams SE, Argraves WS. LDL receptor-related protein (LRP): A multiligand receptor. Fibrinolysis 1994; 8 Suppl. 1: 204-15.
46. Li H, Kuo A, Kochan J, Strickland D, Kariko K, Barnathan ES, Cines DB. Endocytosis of urokinase-plasminogen activator inhibitor type 1 complexes bound to a chimeric transmembrane urokinase receptor. J Biol Chem 1994; 269: 8153-8.
47. Nykjaer A, Petersen CM, Moller B, Jensen PA, Moestrup SK, Holtet TL, Etzerodt M, Thogersen HC, Munch M, Andreasen PA, Gliemann J. Purified alpha-2-macroglobulin receptor/LDL receptor-related protein binds urokinase-plasminogen activator inhibitor type-1 complex: evidence that the alpha-2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. J Biol Chem 1992; 267: 14543-6.
48. Lopez-Pedrera C, Velasco F, Dorado G, Torres A, Felez J. Tissue factor expression in leukemic cells correlates with myeloid differentiation. Haemostasis 1994; 24: 309.
49. Picone R, Kajitaniak EL, Nielsen LS, Behrendt N, Mastronicola MR, Cubellis MV, Stoppelli MP, Pedersen S, Danø K, Blasi F. Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate. J Cell Biol 1989; 108: 693-702.
50. Kirchheimer JC. Modulation of receptor bound urokinase-type plasminogen activator on human monocytes by non-steroidal antiinflammatory drugs. Scand J Rheumatol 1993; 22: 53-7.
51. 3 and their combination. Thromb Res 1993; 69: 353-9.
52. Nishizuka Y. Studies and perspectives of protein kinase C. Science 1986; 233: 305-12.
53. Stopelli MP, Corti A, Soffientini A, Cassani G, Blasi F, Assoian RK. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc Natl Acad Sci USA 1985; 82: 4939-43.
54. Sherman LA, Lee J. Specific binding of soluble fibrin to macrophages. J Exp Med 1977; 145: 76-85.
55. Alitalo R. Induced differentiation of K562 leukemia cells: A model for studies of gene expression in early megakaryoblasts. Leukemia Res 1990; 14: 501-14.
56. Miles LA, Fowler BJ, Jardi M, Schleef RR, Félez J. Comparison of urokinase receptor expression in platelets and megakaryocytes. Blood 1995; 86 (Suppl 1): 556a (Abstr).
57. Plow EF, Miles LA. Plasminogen receptors in the mediation of pericellular proteolysis. Cell Differ Dev 1990; 32: 293-8.
58. Miles LA. Regulation of fibrinolysis and proteolysis by plasminogen receptors. Biol Clin Hematol 1993; 15: 107-15.
59. Felez J, Miles LA, Fabregas P, Jardi M, Plow EF, Lijnen HR. Characterization of Cellular Binding Sites and Interactive Regions within Reactants Required for Enhancement of Plasminogen Activation by tPA on the Surface of Leukocytic Cells. Thromb Haemost 1996; 76: 577-84.
60. Lopez-Alemany R, Longstaff C, Fabregas P, Jardi M, Merton E, Felez J. Inhibition of plasmin generation on cell surfaces by monoclonal antibodies against a 55-60 kDa plasminogen receptor. Fibrinolysis 1996; 10: 5-A: 14. Abstract.
61. Vassalli JD, Pepper SM. Membrane Protease in Focus. Nature 1994; 370: 14-5.
62. Pepper MS, Sappino AP, Stocklin R, Montesano R, Orci L, Vassalli JD. Upregulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol 1993; 122: 673-84.
63. Conese M, Blasi F. Urokinase/urokinase receptor system: Internalization/degradation of urokinase-serpin complexes: Mechanism and regulation. Biol Chem Hoppe Seyler 1995; 376: 143-55.
64. Claxton DF, Reading CL, Nagarajan L, Tsujimoto Y, Andersson BS, Estev E, Cork A, Huh YO, Trujillo J, Deisseroth AB. Correlation of CD2 Expression with PML Gene Breakpoints in patients with acute promyelocytic leukemia. Blood 1992; 80: 582-6.
65. Moller LB, Pöllänen J, Ronne E, Pedersen N, Blasi F. N-linked glycosylation of the ligand-binding domain of the human urokinase receptor contributes to the affinity for its ligand. J Biol Chem 1993; 268: 11152-9.
66. Pyke C, Græm N, Ralfkiær E, Ronne E, Hoyer-Hansen G, Brünner N, Danø K. Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. Cancer Res 1993; 53: 1911-5.
67. Pyke C, Kristensen P, Palkfjaer E, Grondhal-Hansen J, Eriksen J, Blasi F, Danø K. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am J Pathol 1991; 138: 1059-67.